Percutaneous Closure of Huge Patent Ductus Arterious Associated with Anomalous Inferior Vein Cava Drainage and Dextrocardia with Muscular Ventricular Septal Defect Occluder
Tao Zhou,Xiongjie Shen,Shenghua Zhou,Shouliang Qi,Zhenfei Fang,Xiaoling Lu
DOI: https://doi.org/10.1097/00029330-200601010-00012
2006-01-01
Abstract:Transcatheter occlusion of patent ductus arterious (PDA) using various occluders and coils has been a well-established method1-5 since Porstmann and colleagues6 reported the first case in 1967. However, when patients associated with anomalous inferior vein cava drainage or/and huge high pulmonary artery pressure ductus (HPAP-PDA), the method is not suitable. First, it is unfeasible to carry out the procedure via femoral vein. Second, in the presence of high pulmonary artery pressure such devices including the Amplatzer ductu occluder carry the risk of embolising into the aorta.7 The muscular ventricular septal defect occluder (MVSDO), which is a device for transcatheter closure of muscular ventricular septal defect, may be more suitable for using with HPAP-PDA as its double disk tends to anchor the device, preventing embolisation into the aorta. We present a patient, who is suffering from huge PDA associated with anomalous inferior vein cava drainage and dextrocardia, in whom percutaneous closure of PDA using MVSDO was successfully accomplished via transjugular approach. CASE REPORT A 30-year-old man was admitted to hospital because of intermittent hemoptysis and fatigue on exertion in December 2004. No obvious murmur was found on physical examination and a loud P2 was heard in the pulmonary area. The ECG showed dextrocardia. Transthoracic echocardi-ography revealed dextrocardia and arterious ductus between descending aorta and left pulmonary artery, the diameter of ductus was about 7 mm; the position of aorta and pulmonary artery was normal and the systolic pressure of pulmonary artery was about 86 mmHg. The abdominal echocardiography showed total situs inversus and accessory spleen. After percutaneous puncture of the femoral artery and vein, a complete haemodynamic evaluation was performed with pressure and saturation measurements taken in all cardiac chambers. In the procedure of cardiac catheterization, the routing catheterization was abnormal. So the inferior vein cava angiography was performed with 6F pigtail catheter (Cordis, USA). Anomalous inferior vein cava drainage was found; the blood in inferior vein cava was drained into right atrium via zygos vein (Fig. 1). A huge PDA, shape of which was tube, was found in descending aortic angiography and the minimal diameter was 18 mm (Fig. 2). The pressure of pulmonary artery was 111/66 mmHg and the oxygen saturation of the aorta was 97%. Due to the interruption of the inferior vena cava, the closure was attempted via right internal jugular approach. Initially, we tried to send 6F MP catheter to right atrium from superior vena cava by controlling hydrophilic-coated guidewire (Terumo, Japan), but it was very difficult for the catheter and guide-wire to enter into hepatic vein. Fortunately, 6F pigtail catheter was introduced to right ventricle from superior vena cava through right atrium utilizing the angle of right atrium and hepatic vein after trying several times, and then passed to main pulmonary artery.Fig. 1.: Fluoroscopic image of the inferior vein cava angiography in the lateral projection.Fig.: 2. Fluoroscopic image of the descending aortic angiography showing huge PDA.Obviously, it is impossible to send pigtail catheter to descending aorta through ductus from main pulmonary artery by manipulating guidewire, so 6F pigtail catheter was exchanged for MP catheter by 260 mm hydrophilic-coated guidewire. The MP catheter and hydrophilic- coated guidewire were introduced descending aorta fortunately by controlling the hydrophilic-coated guidewire. A 10F delivery sheath (Lifetech Scientic Inc, China) was then passed over the guidewire from right internal jugular vein into the descending aorta. After careful aspiration and flushing, a 24/26 mm PDA occluder (Lifetech Scientic Inc, China) was advanced within the sheath until it reached the descending aorta. The occluder was opened in arterious ductus, but the figure of the PDA occluder was not ideal and large residual shunting was found in transthoracic echocardiography. After taking huge PDA and severe pulmonary hypertension into consideration, we decided to choose MVSDO. 14F delivery sheath (Lifetech Scientic Inc, China) was sent to the descending aorta, after duplicating above procedures, a 26 mm MVSDO (Lifetech Scientic Inc, China) was deployed in arterious ductus. After 15 minutes, the pressure of pulmonary artery was 78/30 mmHg, the diastolic pressure of aorta heightened 15 mmHg and the oxygen saturation of pulmonary artery was 77%. No residual shunting was found in descending aortic angiography (Fig. 3) and no pressure gradient was found during drawing catheter from ascending aorta to descending aorta. The shape of the occluder was ideal after the occluder was released (Fig. 4). The total time of operation was about 2 hours and the fluoro time was about 18 minutes. The clinical and haemodynamic data before and after occlusion are shown in the Table.Fig.: 3. Fluoroscopic image of the descending aortic angiography after MVSDO was deployed.Fig.: 4. Fluoroscopic image after the occluder was released in the lateral projection.Table: Clinical and haemodynamic data of the caseDISCUSSION Congenital interruption of inferior vein cava is uncommon,8 which brings some troubles in percutaneous closure of congenital heart disease (CHD). Under such condition, it is unfeasible to carry out the procedure via femoral vein. Alternative approach such as internal jugular vein or subclavian vein needs to be considered. In 2004, we performed percutaneous closure of ventricular septal defect (VSD) associated with anomalous inferior vein cava drainage via transjugular approach successfully.9 The technique of transcatheter treatment of CHD via internal jugular vein was similar to the procedure via femoral vein, but it is more difficult that catheter and occluder are introduced to the destination; the operator must have rich experience and handle such rare things unhurried. Extrastiff guidewire or hydrophilic-coated guidewire may be used for greater support was needed in the procedure. However, dextrocardia brought more trouble in the procedure, and the problem may be resolved partly by inversing the images. The common PDA occluders are not suitable for the patient because the PDA is huge and the pressure of pulmonary artery is very high. Under such conditions, the PDA occluders are easy to fall into the aorta. We had performed transcathter closure PDA more than 150 cases since 1991, two cases among which, both complicated with severe pulmonary hypertension, needed the surgical help for the PDA occluders fell into the aorta. In this case, the figure of the PDA occluder, which is 6-8 mm larger than the minimal diameter of PDA, is not ideal and residual shunting was presented. So we gave up using PDA occluders. Thanopoulos and colleagues7 had fulfilled transcatheter closure of high pulmonary artery pressure PDA with the Amplatzer muscular ventricular septal defect occluder successfully. In their study, seven patients had complete closure with the Amplatzer muscular ventricular septal defect occluder successfully. In their study, seven patients had complete closure with no evidence of device recanalisation, migration, or throm-boembolism and no obstruction of the left pulmonary artery or the aorta was noted. In China, transcatheter closure of a very large PDA with severe pulmonary hypertension using Amplatzer MVSDO was reported in 2005.10 In the setting of high pulmonary artery pressure there is a real possibility of systemic embolisation. The MVSDO is available in a variety of sizes and its retention disk system ensures secure positioning in the pulmonary orifice of duct and prevents device embolisation into the systemic circulation in the presence of high pulmonary artery pressure. In addition, the MVSDO exerts an exaggerated stenting effect on the duct wall, showing greater stability than PDA occluder. So we chose MVSDO instead of PDA occluder for its merits under such circumstances. No complications were observed in the early postprocedural period or during the one-year follow up in this case. The success of this case and the experience of Thanopoulos and colleagues7 demonstrate that MVSDO is feasible, effective, and safe for transcatheter closure of large HPAP-PDAs. But further studies are required to document its efficacy, safety, and long-term results in a large number of patients.